Nicholas Ward is a reporter based in North and West South Australia, focusing on local news and developments in the region. He writes for Seeking Alpha and the Australian Broadcasting Corporation (ABC), covering a range of topics including stock market analysis, agricultural issues, and regional news.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Nicholas Ward's coverage heavily focuses on finance, particularly stock market investments and dividend growth. He also covers regional development, tourism, and culture & society.
If you're looking to pitch to Nicholas, consider offering insights into stock market trends or investment analysis related to the Australian financial market. Additionally, if you have expertise in regional South Australia's economic development or tourism industry trends, your input could be valuable for his articles.
Considering his interest in government announcements and citing data in his coverage attributes, pitches with relevant statistical information or exclusive access to newsworthy government announcements may catch his attention.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Summary The author has owned Starbucks stock for a decade and has seen significant returns, with dividends pushing total returns above 200%.
By: Nicholas Ward
There is potential in Starbucks shares despite rising concerns about worker costs, unionization threats, and geopolitical tension with China. See more on SBUX.
Summary Booking Holdings Inc. has a strong track record of positive EPS growth, with 19 out of the last 20 years showing growth.
By: Nicholas Ward
CME Group pays a high dividend yield, with potential for special dividends, giving it a sneaky-high yield. See why I rate CME stock as a buy.
Summary CME Group benefits from market volatility and its toll booth-like business model, making it a profitable investment.
By: Nicholas Ward
Summary I focus on dividend growth stocks as a strategy for long-term outperformance and financial freedom.
Zoetis has a strong position in the animal health market, with increased pricing power and limited competition. Click here for why I am bullish on ZTS stock.
By: Nicholas Ward
Ecolab, a materials stock in the specialty chemicals industry, is poised for growth due to AI proliferation and its expertise in water and infection. Read more here.
By: Nicholas Ward
Summary Ecolab, a materials stock in the specialty chemicals industry, is set to experience major growth due to AI proliferation.
By: Nicholas Ward
Summary MSCI Inc. is nearing fair value after an 11% sell-off, making it an attractive buying opportunity.
(833) 317-6278 
